Ely Benaim
Nessuna posizione attualmente
Patrimonio netto: 449 675 $ in data 31/03/2024
Profilo
Ely Benaim è Chief Medical Officer di NovoCure Ltd. In passato il Dr. Benaim ha occupato la posizione di Vice Presidente-Affari clinici presso Sangamo Therapeutics, Inc., Chief Medical Officer & SVP-Regulatory Affairs presso Berg Pharma LLC, Senior Director-Clinical Research presso Millennium Pharmaceuticals, Inc., Chief Medical Officer di Rexahn Pharmaceuticals, Inc., Senior Director-Global Oncology presso Salmedix, Inc. e Assistant Professor presso la University of Tennessee. Il Dr. Benaim ha ricevuto un dottorato dall'Università Centrale del Venezuela.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVOCURE LTD.
0.03% | 06/01/2023 | 28 770 ( 0.03% ) | 449 675 $ | 31/03/2024 |
Precedenti posizioni note di Ely Benaim
| Società | Posizione | Fine |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 17/01/2023 |
| REXAHN PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2019 |
| Berg Pharma LLC | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
Formazione di Ely Benaim
| Central University of Venezuela | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| Berg Pharma LLC |
- Borsa valori
- Insiders
- Ely Benaim
